87 related articles for article (PubMed ID: 20148873)
1. Expression of oligodendrocyte and myelin genes is not altered in peripheral blood cells of patients with first-episode schizophrenia and bipolar disorder.
Gutiérrez-Fernández A; González-Pinto A; Vega P; Barbeito S; Matute C
Bipolar Disord; 2010 Feb; 12(1):107-9. PubMed ID: 20148873
[No Abstract] [Full Text] [Related]
2. Effect of a functional single nucleotide polymorphism in the 2',3'-cyclic nucleotide 3'-phosphodiesterase gene on the expression of oligodendrocyte-related genes in schizophrenia.
Iwamoto K; Ueda J; Bundo M; Nakano Y; Kato T
Psychiatry Clin Neurosci; 2008 Feb; 62(1):103-8. PubMed ID: 18289148
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms involved in the actions of apotransferrin upon the central nervous system: Role of the cytoskeleton and of second messengers.
Marta CB; Davio C; Pasquini LA; Soto EF; Pasquini JM
J Neurosci Res; 2002 Aug; 69(4):488-96. PubMed ID: 12210842
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of oligodendrocyte precursors is impaired in the prefrontal cortex in schizophrenia.
Mauney SA; Pietersen CY; Sonntag KC; Woo TW
Schizophr Res; 2015 Dec; 169(1-3):374-380. PubMed ID: 26585218
[TBL] [Abstract][Full Text] [Related]
5. Intracellular distribution of myelin protein gene products is altered in oligodendrocytes of the taiep rat.
O'Connor LT; Goetz BD; Couve E; Song J; Duncan ID
Mol Cell Neurosci; 2000 Oct; 16(4):396-407. PubMed ID: 11085877
[TBL] [Abstract][Full Text] [Related]
6. Possible contributions of myelin and oligodendrocyte dysfunction to schizophrenia.
Stewart DG; Davis KL
Int Rev Neurobiol; 2004; 59():381-424. PubMed ID: 15006496
[No Abstract] [Full Text] [Related]
7. The myelin basic protein gene: a prototype for combinatorial mammalian transcriptional regulation.
Farhadi HF; Peterson AC
Adv Neurol; 2006; 98():65-76. PubMed ID: 16400827
[No Abstract] [Full Text] [Related]
8. Convergent evidence for 2',3'-cyclic nucleotide 3'-phosphodiesterase as a possible susceptibility gene for schizophrenia.
Peirce TR; Bray NJ; Williams NM; Norton N; Moskvina V; Preece A; Haroutunian V; Buxbaum JD; Owen MJ; O'Donovan MC
Arch Gen Psychiatry; 2006 Jan; 63(1):18-24. PubMed ID: 16389193
[TBL] [Abstract][Full Text] [Related]
9. Biosynthesis of the myelin 2',3'-cyclic nucleotide 3'-phosphodiesterases.
Gillespie CS; Bernier L; Brophy PJ; Colman DR
J Neurochem; 1990 Feb; 54(2):656-61. PubMed ID: 1688921
[TBL] [Abstract][Full Text] [Related]
10. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder.
Tkachev D; Mimmack ML; Ryan MM; Wayland M; Freeman T; Jones PB; Starkey M; Webster MJ; Yolken RH; Bahn S
Lancet; 2003 Sep; 362(9386):798-805. PubMed ID: 13678875
[TBL] [Abstract][Full Text] [Related]
11. Dysmyelination and reduced myelin basic protein gene expression by oligodendrocytes of SHP-1-deficient mice.
Massa PT; Wu C; Fecenko-Tacka K
J Neurosci Res; 2004 Jul; 77(1):15-25. PubMed ID: 15197735
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of oligodendrocyte differentiation in culture by growth in the presence of a monoclonal antibody to sulfated glycolipid.
Bansal R; Gard AL; Pfeiffer SE
J Neurosci Res; 1988; 21(2-4):260-7. PubMed ID: 2464078
[TBL] [Abstract][Full Text] [Related]
13. Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins.
Flynn SW; Lang DJ; Mackay AL; Goghari V; Vavasour IM; Whittall KP; Smith GN; Arango V; Mann JJ; Dwork AJ; Falkai P; Honer WG
Mol Psychiatry; 2003 Sep; 8(9):811-20. PubMed ID: 12931208
[TBL] [Abstract][Full Text] [Related]
14. The myelin-pathogenesis puzzle in schizophrenia: a literature review.
Karoutzou G; Emrich HM; Dietrich DE
Mol Psychiatry; 2008 Mar; 13(3):245-60. PubMed ID: 17925796
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations in the mouse myelin basic proteins result in a range of dysmyelinating disorders.
Jacobs EC
J Neurol Sci; 2005 Feb; 228(2):195-7. PubMed ID: 15694204
[No Abstract] [Full Text] [Related]
16. CNS myelinogenesis in vitro: myelin basic protein deficient shiverer oligodendrocytes.
Seiwa C; Kojima-Aikawa K; Matsumoto I; Asou H
J Neurosci Res; 2002 Aug; 69(3):305-17. PubMed ID: 12125072
[TBL] [Abstract][Full Text] [Related]
17. Oligodendrocyte maturation is inhibited by bone morphogenetic protein.
See J; Zhang X; Eraydin N; Mun SB; Mamontov P; Golden JA; Grinspan JB
Mol Cell Neurosci; 2004 Aug; 26(4):481-92. PubMed ID: 15276151
[TBL] [Abstract][Full Text] [Related]
18. Isolation of oligodendrocyte-like cells from human umbilical cord blood.
Tracy E; Aldrink J; Panosian J; Beam D; Thacker J; Reese M; Kurtzberg J
Cytotherapy; 2008; 10(5):518-25. PubMed ID: 18608351
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the human MBP promoter in primary cultures of oligodendrocytes: positive and negative cis-acting elements in the proximal MBP promoter mediate oligodendrocyte-specific expression of MBP.
Wrabetz L; Shumas S; Grinspan J; Feltri ML; Bozyczko D; McMorris FA; Pleasure D; Kamholz J
J Neurosci Res; 1993 Nov; 36(4):455-71. PubMed ID: 7505842
[TBL] [Abstract][Full Text] [Related]
20. Implications of protease M/neurosin in myelination during experimental demyelination and remyelination.
Bando Y; Ito S; Nagai Y; Terayama R; Kishibe M; Jiang YP; Mitrovic B; Takahashi T; Yoshida S
Neurosci Lett; 2006 Sep; 405(3):175-80. PubMed ID: 16890353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
